13F Holdings
中文EN

PAIYY Aesthetic Medical International Holdings Group Ltd IFRS Annual reports only

Services-Specialty Outpatient Facilities, NEC · OTC · SEC CIK 1757143 · Reporting currency CNY · Fiscal year ends 12/31

Financial factors as of 2024-12-31 (FY2024), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY10.7%
TTM net income YoY46.7%
TTM EPS YoY50.0%
Revenue 3-yr CAGR5.4%
Net income 3-yr CAGR—

Margins

Gross margin44.7%
Operating margin—
Net margin-2.6%
FCF margin6.5%
EBITDA margin—

Returns

ROE-50.3%
ROA-3.8%
ROIC (approx.)—
Asset turnover1.44x

Leverage & solvency

Liabilities / assets98.1%
Debt / equity2.82x
Current ratio—
Interest coverage—

Cash quality & payout

Operating cash flow / net income-3.99x
Accruals ratio-19.0%
Payout ratio—
Capex / revenue4.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Unit: CNY FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31FY20202020-12-31
Income statement
Revenue755.67M682.59M670.09M645.59M901.57M
Cost of revenue417.88M360.54M314.50M376.09M356.80M
Gross profit337.79M322.05M355.59M269.50M544.78M
SG&A expense100.78M138.60M150.38M206.97M230.65M
Interest expense8.72M14.47M21.64M27.23M29.19M
Pretax income-1.35M-55.06M-94.17M-681.31M-259.49M
Income tax23.73M-15.14M-18.07M-11.80M-12.59M
Net income-19.95M-37.43M-76.25M-586.62M-235.48M
EPS (basic)-0.14-0.28-0.93-8.89-3.61
EPS (diluted)-0.14-0.28-0.93-8.89-3.61
Weighted avg. shares (diluted)143.50M131.66M81.91M65.96M65.30M
Balance sheet
Cash & equivalents42.84M62.34M12.16M39.29M44.38M
Receivables18.38M21.66M25.89M7.77M14.32M
Inventory14.91M15.58M27.85M30.57M33.34M
Current assets————206.16M
PP&E, netmay include right-of-use assets (IFRS)266.24M304.22M320.82M358.75M531.94M
Total assets486.22M560.66M546.37M576.94M1.04B
Current liabilities402.04M411.38M543.84M541.66M301.69M
Short-term debt72.22M73.93M172.77M156.21M135.81M
Long-term debt13.72M31.41M29.11M77.61M75.93M
Total debt85.94M105.34M201.88M233.81M211.75M
Total liabilities476.88M527.03M672.25M763.36M612.35M
Shareholders' equity30.46M48.89M-113.66M-156.67M390.90M
Net debt43.10M43.01M189.72M194.53M167.36M
Cash flow statement
Operating cash flow79.67M74.29M-75.13M51.09M-843,000
Capital expenditure30.60M55.24M1.60M33.24M38.35M
Free cash flow49.07M19.04M-76.72M17.85M-39.20M
Investing cash flow-30.32M-52.25M3.11M-11.53M-127.37M
Financing cash flow-68.55M29.06M45.55M-45.23M17.70M
Depreciation & amortization65.96M65.90M61.48M99.14M106.41M
Stock-based compensation07.51M27.53M35.46M78.97M
Share buybacks2.02M———1.98M

Free plan shows the latest 5 periods; Pro shows all 8 🔒

· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· Amounts are in the company's reporting currency, CNY, not USD; the site does no currency conversion.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.